Evofem Biosciences
OTC: EVFMSan Diego, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
IZ
Ivy ZhangExecutive Officer
SP
Saundra PelletierExecutive Officer, Director
WH
William HallDirector
KC
Kelly CulwellExecutive Officer
JJ
Justin J. FileExecutive Officer
AA
Alexander A. FitzpatrickExecutive Officer
RB
Russell BarransExecutive Officer
GG
Gillian GreerDirector
TL
Thomas LynchDirector
KK
Kim KamdarDirector
CR
Colin RutherfordDirector
LR
Lisa RarickDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$925KraisedJul 2025 · 1 investors · BiotechnologyRule 506(b)
▶$925KraisedJul 2025 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Colin RutherfordDirector
- Ivy ZhangExecutive Officer
- Kim KamdarDirector
- Lisa RarickDirector
- Saundra PelletierExecutive Officer, Director
- Tony O'BrienDirector
- Offering amount
- $925K
- Amount sold
- $925K
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$750KraisedApr 2025 · 1 investors · BiotechnologyRule 506(b)
▶$750KraisedApr 2025 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lisa RarickDirector
- Ivy ZhangExecutive Officer
- Saundra PelletierExecutive Officer, Director
- Colin RutherfordDirector
- Tony O'BrienDirector
- Kim KamdarDirector
- Offering amount
- $1.5M
- Amount sold
- $750K
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedAug 2024 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedAug 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ivy ZhangExecutive Officer
- Kim KamdarDirector
- Colin RutherfordDirector
- Lisa RarickDirector
- Tony O'BrienDirector
- Saundra PelletierExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedAug 2024 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedAug 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lisa RarickDirector
- Saundra PelletierExecutive Officer, Director
- Tony O'BrienDirector
- Colin RutherfordDirector
- Kim KamdarDirector
- Ivy ZhangExecutive Officer
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.9MraisedOct 2023 · 14 investors · BiotechnologyRule 506(b)
▶$2.9MraisedOct 2023 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Colin RutherfordDirector
- Ivy ZhangExecutive Officer
- Saundra PelletierExecutive Officer, Director
- Tony O'BrienDirector
- Lisa RarickDirector
- Kim KamdarDirector
- Offering amount
- $2.9M
- Amount sold
- $2.9M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedMar 2023 · 4 investors · BiotechnologyRule 506(b)
▶$1.4MraisedMar 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kim KamdarDirector
- Lisa RarickDirector
- Colin RutherfordDirector
- Tony O'BrianDirector
- Justin FileExecutive Officer
- Saundra PelletierExecutive Officer, Director
- Gillian GreerDirector
- Offering amount
- $1.4M
- Amount sold
- $1.4M
- Sales commissions
- $572K
- Placement agents
- JOSEPH GUNNAR & CO. LLC
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.3MraisedFeb 2023 · 8 investors · BiotechnologyRule 506(b)
▶$2.3MraisedFeb 2023 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Saundra PelletierExecutive Officer, Director
- Colin RutherfordDirector
- Gillian GreerDirector
- Justin FileExecutive Officer
- Lisa RarickDirector
- Kim KamdarDirector
- Tony O'BrianDirector
- Jenny YipDirector
- Offering amount
- $2.3M
- Amount sold
- $2.3M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25MraisedOct 2020 · 2 investors · BiotechnologyRule 506(b)
▶$25MraisedOct 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Justin J FileExecutive Officer
- William HallDirector
- Russell BarransExecutive Officer
- Alexander A. FitzpatrickExecutive Officer
- Lisa RarickDirector
- Kelly CulwellExecutive Officer
- Tony O'BrienDirector
- Kim KamdarDirector
- Gillian GreerDirector
- Colin RutherfordDirector
- Saundra PelletierExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.